Elucida Oncology Revenue and Competitors

Monmouth Junction, NJ USA

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Elucida Oncology's estimated annual revenue is currently $4.5M per year.(i)
  • Elucida Oncology's estimated revenue per employee is $155,000

Employee Data

  • Elucida Oncology has 29 Employees.(i)
  • Elucida Oncology grew their employee count by -26% last year.

Elucida Oncology's People

NameTitleEmail/Phone
1
Head Formulation Development, C’ Dot-Drug-ConjugateReveal Email/Phone
2
Chief Medical OfficerReveal Email/Phone
3
Staff ScientistReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$8.7M562%N/AN/A
#2
$0.2M10%N/AN/A
#3
$5.7M37-33%N/AN/A
#4
$114.8M5296%N/AN/A
#5
$0.8M50%N/AN/A
#6
$0.6M40%N/AN/A
#7
$14.7M83-22%$206.4MN/A
#8
$492.2M1834-15%$568MN/A
#9
$1.9M1271%N/AN/A
#10
$4.8M317%N/AN/A
Add Company

What Is Elucida Oncology?

Elucida Oncology, Inc., is a clinical development stage company based on proprietary ultra-small C-Dot technology to find, see and treat an array of solid tumor cancers. Developed and clinically translated by Memorial Sloan-Kettering Cancer Center and Cornell University, C-Dots have published human safety and tumor-specific clinical data. Elucida Oncology is currently progressing through a broad clinical trial program while continuing to drive a future portfolio through ongoing innovation.

keywords:N/A

N/A

Total Funding

29

Number of Employees

$4.5M

Revenue (est)

-26%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Elucida Oncology News

2022-04-06 - Elucida Oncology's Lead Clinical Candidate ELU001 to Be ...

MONMOUTH JUNCTION, N.J., April 04, 2022 (GLOBE NEWSWIRE) -- Elucida Oncology, a clinical-stage biotechnology company developing the next...

2022-03-22 - Elucida Oncology to Present at Two Upcoming Scientific ...

Elucida Oncology, Inc., is a clinical-stage biotechnology company pioneering the next frontier in targeted cancer therapy with its first-in-...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$4.5M297%N/A
#2
$6M30-12%N/A
#3
$3.6M3115%N/A
#4
$3.9M346%N/A
#5
$4.2M36-10%N/A